Literature DB >> 27867567

Influence of old pulmonary tuberculosis on the management of secondary spontaneous pneumothorax in patients over the age of 70 years.

Sang Cjeol Lee1, Deok Heon Lee1.   

Abstract

BACKGROUND: This study aimed to investigate the treatment outcomes and influence of old pulmonary tuberculosis (TB) in elderly patients (over 70 years) with secondary spontaneous pneumothorax (SSP).
METHODS: A retrospective analysis was performed on patients with SSP between January 2002 and December 2014. Treatment outcomes including chest tube duration (CTD), type and complication of surgery, recurrence and survival rate were obtained from the review of medical records and analyzed statistically.
RESULTS: Two hundred and sixteen consecutive cases were recruited. Of these, 134 (62.0%) did not have old pulmonary TB [non-tuberculosis (NTB) group], and the other 82 (38.0%) had experienced pulmonary TB (TB group). More thoracoscopic surgeries had been performed in the NTB group (P=0.038). More postoperative complications developed in the TB group (P=0.038). Total CTD and postoperative CTD in the TB group were significantly longer (P=0.015 and 0.030, respectively). However, recurrence-free survival and overall survival rate were not significantly different between the TB and NTB groups.
CONCLUSIONS: Old pulmonary TB in elderly patients with SSP made their treatment more complicated. However, surgery might be considered in highly selected patients regardless of old pulmonary TB, and could be conducted with acceptable morbidity and mortality.

Entities:  

Keywords:  Pulmonary tuberculosis; pneumothorax and elderly

Year:  2016        PMID: 27867567      PMCID: PMC5107527          DOI: 10.21037/jtd.2016.10.73

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  26 in total

Review 1.  Spontaneous pneumothorax.

Authors:  S A Sahn; J E Heffner
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

2.  Lung volume reduction surgery for emphysema: correlation of CT and V/Q imaging with physiologic mechanisms of improvement in lung function.

Authors:  Andetta R Hunsaker; Edward P Ingenito; John J Reilly; Philip Costello
Journal:  Radiology       Date:  2002-02       Impact factor: 11.105

3.  BTS guidelines for the management of spontaneous pneumothorax.

Authors:  M Henry; T Arnold; J Harvey
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

4.  Radiological diagnosis and follow-up of pulmonary tuberculosis.

Authors:  Molly Roy; Stephen Ellis
Journal:  Postgrad Med J       Date:  2010-09-24       Impact factor: 2.401

5.  Surgical treatment for secondary pneumothorax in patients aged more than 80 years.

Authors:  Hisayuki Shigematsu; Akio Andou; Ryohei Higashi
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-21       Impact factor: 5.209

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

Review 8.  Decision making in the management of secondary spontaneous pneumothorax in patients with severe emphysema.

Authors:  K Robert Shen; Robert J Cerfolio
Journal:  Thorac Surg Clin       Date:  2009-05       Impact factor: 1.750

Review 9.  Surgical resection of lung cancer in the elderly.

Authors:  Carlos Bravo-Iñiguez; Mauricio Perez Martinez; Katherine W Armstrong; Michael Thomas Jaklitsch
Journal:  Thorac Surg Clin       Date:  2014-10-23       Impact factor: 1.750

10.  Chronic obstructive airways disease following treated pulmonary tuberculosis.

Authors:  P A Willcox; A D Ferguson
Journal:  Respir Med       Date:  1989-05       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.